Clinical Trials Directory

Trials / Completed

CompletedNCT02375516

Preventing Drug Abuse Among Hispanic Adolescents

Drug Abuse Prevention Programming for Hispanic Adolescents

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
678 (actual)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
12 Years – 15 Years
Healthy volunteers
Accepted

Summary

The planned research aims to delay the onset of drug use and reduce harmful use and abuse among Hispanic youths. The culturally-tailored prevention program will be delivered to youths by computer. Over 5 years, the program will be developed and tested in a randomized clinical trial. The intervention program will include 10 initial sessions, followed by annual booster sessions. Outcome measurements will involve baseline, post-intervention, and three annual follow-up data collections. The study's primary hypothesis is that rates of 30-day alcohol and drug use will be lower among participants assigned to receive the intervention. If proven to be efficacious, the program will be revised and disseminated nationally.

Detailed description

America's largest ethnic minority group, Hispanics are also a youthful population: one-third of Hispanic Americans are less than 18 years old. Unfortunately, young Hispanic Americans are an at-risk population more likely than their majority culture peers to drop out of school, become involved in the criminal justice system, fall prey to violence, and face lifelong economic problems. Hispanic youths are also at risk for early drug use and subsequent harmful use and abuse. As early as eighth grade and relative to their Black and White peers, Hispanic adolescents report higher rates of most harmful substances. Drug use continues to pose problems for Hispanic youths throughout adolescence and into adulthood.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPrevention ProgramYouths in the intervention-arm will interact online with the initial intervention program between pretest and posttest measurement occasions and will interact with booster sessions subsequent to 1- and 2-year follow-up measurement occasions. Owing to the expense associated with developing a treatment-as-usual intervention for computer delivery in the control arm, youths assigned to the control arm will receive no intervention.

Timeline

Start date
2012-09-01
Primary completion
2019-07-01
Completion
2021-04-07
First posted
2015-03-02
Last updated
2021-08-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02375516. Inclusion in this directory is not an endorsement.